Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Prostate specific antigen (PSA) is a blood-based biomarker used for the detection and surveillance of prostate cancer (PCa) 1. PCa can cause disruption of the prostate’s cellular architecture, which ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.
Investigators assessed PSA response to treatment at various time points for their relative abilities to predict disease progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC ...
The goal of this retrospective study was to investigate the effect of total PSA, PSA velocity (PSAvel), and PSA doubling time (PSAdt) on the 11C-choline PET/CT detection rate in 190 men with PSA ...
The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which ...
BARCELONA, Spain — Simple, temporary lifestyle changes may be able to spare men with mildly increased prostate-specific antigen (PSA) levels from having to endure a prostate biopsy, results of a ...
While the benefits of screening tests for cervical cancer, breast cancer, and colorectal cancer are widely accepted, screening for prostate cancer remains controversial to some. The main screening ...